Michele J. Orza, ScD
Over the past decade, interest in global health has burgeoned, and the United States’ investment in it has more than quintupled. HIV/AIDS, SARS, contaminated medical products, outbreaks of food poisoning, and most recently the H1N1 (Swine) Flu pandemic have added to an increasing appreciation for the global nature of such things as determinants of health, threats to health, the evidence base for health practice, the health workforce, the food supply, and the marketplace for health products and technologies. At the same time, the field of global health has been expanding and evolving, increasing its emphasis on evidence-based programming and on careful monitoring and evaluation to learn how limited global health funding can be most effectively spent.
The Obama administration’s Global Health Initiative proposes $63 billion over six years to partner with low- and middle-income countries to improve their health outcomes by strengthening their health systems. The administration released the implementation plan for the initiative in the form of a consultation document in February 2010, seeking input from many quarters. This document sets many goals and targets with respect to HIV/AIDS, malaria, tuberculosis, maternal health, child health, nutrition, family planning and reproductive health, neglected tropical diseases, and health systems strengthening.
This Forum session examined the current challenges and opportunities for global health, how U.S. global health policy is evolving, and the U.S. Global Health Initiative consultative process.
Jennifer Kates, Vice President and Director of Global Health Policy & HIV, the Kaiser Family Foundation; Jeffrey P. Koplan, MD, Vice President for Global Health and Director, Emory Global Health Institute, Emory University; Ambassador Eric Goosby, MD, United States Global AIDS Coordinator, U.S. Department of State
Materials distributed at the meeting include: